Absorption of two antibacterial drugs, cephalexin and co-trimoxazole, in malabsorption syndromes.
D002446:Celiac Disease / Q000378:metabolism; D002506:Cephalexin / Q000378:metabolism*; D002792:Cholestyramine Resin / Q000009:adverse effects; D003424:Crohn Disease / Q000378:metabolism; D003550:Cystic Fibrosis / Q000378:metabolism; D004240:Diverticulum / Q000378:metabolism; D004338:Drug Combinations; D006801:Humans; D007408:Intestinal Absorption; D008286:Malabsorption Syndromes / Q000139:chemically induced / Q000378:metabolism*; D013420:Sulfamethoxazole / Q000378:metabolism*; D013997:Time Factors; D014295:Trimethoprim / Q000378:metabolism*
D004338:Drug Combinations; D002792:Cholestyramine Resin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002506:Cephalexin